nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—Microtubule Inhibition—Paclitaxel—lung cancer	0.483	0.58	CiPCiCtD
Griseofulvin—Microtubule Inhibition—Docetaxel—lung cancer	0.349	0.42	CiPCiCtD
Griseofulvin—CYP1A2—Erlotinib—lung cancer	0.0123	0.117	CbGbCtD
Griseofulvin—CYP3A4—Topotecan—lung cancer	0.0119	0.113	CbGbCtD
Griseofulvin—CYP3A4—Gefitinib—lung cancer	0.0109	0.104	CbGbCtD
Griseofulvin—CYP3A4—Teniposide—lung cancer	0.0106	0.101	CbGbCtD
Griseofulvin—CYP1A2—Etoposide—lung cancer	0.00889	0.0847	CbGbCtD
Griseofulvin—CYP3A4—Vinorelbine—lung cancer	0.00839	0.0799	CbGbCtD
Griseofulvin—CYP3A4—Crizotinib—lung cancer	0.00667	0.0636	CbGbCtD
Griseofulvin—CYP3A4—Erlotinib—lung cancer	0.00644	0.0613	CbGbCtD
Griseofulvin—CYP3A4—Paclitaxel—lung cancer	0.00589	0.0561	CbGbCtD
Griseofulvin—CYP3A4—Irinotecan—lung cancer	0.00581	0.0554	CbGbCtD
Griseofulvin—CYP3A4—Vinblastine—lung cancer	0.00517	0.0492	CbGbCtD
Griseofulvin—CYP3A4—Etoposide—lung cancer	0.00466	0.0444	CbGbCtD
Griseofulvin—CYP3A4—Docetaxel—lung cancer	0.00426	0.0406	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—lung cancer	0.00318	0.0303	CbGbCtD
Griseofulvin—Urticaria—Pemetrexed—lung cancer	0.000241	0.00468	CcSEcCtD
Griseofulvin—Erythema multiforme—Erlotinib—lung cancer	0.00024	0.00466	CcSEcCtD
Griseofulvin—Urticaria—Gefitinib—lung cancer	0.000239	0.00465	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vinorelbine—lung cancer	0.000239	0.00465	CcSEcCtD
Griseofulvin—Asthenia—Crizotinib—lung cancer	0.000238	0.00463	CcSEcCtD
Griseofulvin—Candida infection—Docetaxel—lung cancer	0.000238	0.00462	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Cisplatin—lung cancer	0.000237	0.00461	CcSEcCtD
Griseofulvin—Neuropathy—Docetaxel—lung cancer	0.000234	0.00454	CcSEcCtD
Griseofulvin—Agranulocytosis—Vinorelbine—lung cancer	0.000228	0.00443	CcSEcCtD
Griseofulvin—Diarrhoea—Crizotinib—lung cancer	0.000227	0.00441	CcSEcCtD
Griseofulvin—Hypersensitivity—Pemetrexed—lung cancer	0.000223	0.00434	CcSEcCtD
Griseofulvin—Hypersensitivity—Gefitinib—lung cancer	0.000222	0.00431	CcSEcCtD
Griseofulvin—Erythema—Erlotinib—lung cancer	0.000221	0.00429	CcSEcCtD
Griseofulvin—Dizziness—Crizotinib—lung cancer	0.000219	0.00426	CcSEcCtD
Griseofulvin—Asthenia—Pemetrexed—lung cancer	0.000218	0.00423	CcSEcCtD
Griseofulvin—Asthenia—Gefitinib—lung cancer	0.000216	0.0042	CcSEcCtD
Griseofulvin—Vomiting—Crizotinib—lung cancer	0.000211	0.0041	CcSEcCtD
Griseofulvin—Rash—Crizotinib—lung cancer	0.000209	0.00406	CcSEcCtD
Griseofulvin—Dermatitis—Crizotinib—lung cancer	0.000209	0.00406	CcSEcCtD
Griseofulvin—Diarrhoea—Pemetrexed—lung cancer	0.000207	0.00403	CcSEcCtD
Griseofulvin—Diarrhoea—Gefitinib—lung cancer	0.000206	0.00401	CcSEcCtD
Griseofulvin—Leukopenia—Vinblastine—lung cancer	0.000205	0.00399	CcSEcCtD
Griseofulvin—Proteinuria—Methotrexate—lung cancer	0.000204	0.00397	CcSEcCtD
Griseofulvin—Angioedema—Topotecan—lung cancer	0.000204	0.00396	CcSEcCtD
Griseofulvin—Feeling abnormal—Teniposide—lung cancer	0.000202	0.00393	CcSEcCtD
Griseofulvin—Protein urine present—Methotrexate—lung cancer	0.000201	0.00391	CcSEcCtD
Griseofulvin—Dizziness—Pemetrexed—lung cancer	0.0002	0.0039	CcSEcCtD
Griseofulvin—Leukopenia—Topotecan—lung cancer	0.0002	0.00388	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Methotrexate—lung cancer	0.000197	0.00383	CcSEcCtD
Griseofulvin—Nausea—Crizotinib—lung cancer	0.000197	0.00383	CcSEcCtD
Griseofulvin—Urticaria—Teniposide—lung cancer	0.000195	0.00379	CcSEcCtD
Griseofulvin—Vomiting—Pemetrexed—lung cancer	0.000193	0.00375	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Gemcitabine—lung cancer	0.000192	0.00374	CcSEcCtD
Griseofulvin—Vomiting—Gefitinib—lung cancer	0.000192	0.00372	CcSEcCtD
Griseofulvin—Rash—Pemetrexed—lung cancer	0.000191	0.00371	CcSEcCtD
Griseofulvin—Dermatitis—Pemetrexed—lung cancer	0.000191	0.00371	CcSEcCtD
Griseofulvin—Erythema—Vinorelbine—lung cancer	0.000191	0.00371	CcSEcCtD
Griseofulvin—Rash—Gefitinib—lung cancer	0.00019	0.00369	CcSEcCtD
Griseofulvin—Dermatitis—Gefitinib—lung cancer	0.00019	0.00369	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Methotrexate—lung cancer	0.00019	0.00368	CcSEcCtD
Griseofulvin—Agranulocytosis—Gemcitabine—lung cancer	0.000183	0.00356	CcSEcCtD
Griseofulvin—Hypersensitivity—Teniposide—lung cancer	0.000181	0.00352	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Docetaxel—lung cancer	0.000181	0.00351	CcSEcCtD
Griseofulvin—Nausea—Pemetrexed—lung cancer	0.00018	0.0035	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Cisplatin—lung cancer	0.000179	0.00348	CcSEcCtD
Griseofulvin—Nausea—Gefitinib—lung cancer	0.000179	0.00348	CcSEcCtD
Griseofulvin—Asthenia—Teniposide—lung cancer	0.000176	0.00342	CcSEcCtD
Griseofulvin—Angioedema—Vinorelbine—lung cancer	0.000174	0.00339	CcSEcCtD
Griseofulvin—Leukopenia—Vinorelbine—lung cancer	0.000171	0.00332	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—lung cancer	0.000171	0.00332	CcSEcCtD
Griseofulvin—Paraesthesia—Vinblastine—lung cancer	0.000168	0.00327	CcSEcCtD
Griseofulvin—Diarrhoea—Teniposide—lung cancer	0.000168	0.00327	CcSEcCtD
Griseofulvin—Erythema multiforme—Gemcitabine—lung cancer	0.000166	0.00323	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Etoposide—lung cancer	0.000164	0.00319	CcSEcCtD
Griseofulvin—Paraesthesia—Topotecan—lung cancer	0.000163	0.00318	CcSEcCtD
Griseofulvin—Insomnia—Erlotinib—lung cancer	0.000163	0.00317	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Paclitaxel—lung cancer	0.000161	0.00313	CcSEcCtD
Griseofulvin—Dyspepsia—Topotecan—lung cancer	0.00016	0.00311	CcSEcCtD
Griseofulvin—Dyspepsia—Erlotinib—lung cancer	0.000159	0.00308	CcSEcCtD
Griseofulvin—Fatigue—Topotecan—lung cancer	0.000157	0.00305	CcSEcCtD
Griseofulvin—Agranulocytosis—Etoposide—lung cancer	0.000156	0.00304	CcSEcCtD
Griseofulvin—Vomiting—Teniposide—lung cancer	0.000156	0.00303	CcSEcCtD
Griseofulvin—Fatigue—Erlotinib—lung cancer	0.000155	0.00302	CcSEcCtD
Griseofulvin—Rash—Teniposide—lung cancer	0.000155	0.00301	CcSEcCtD
Griseofulvin—Dermatitis—Teniposide—lung cancer	0.000155	0.00301	CcSEcCtD
Griseofulvin—Feeling abnormal—Vinblastine—lung cancer	0.000154	0.003	CcSEcCtD
Griseofulvin—Headache—Teniposide—lung cancer	0.000154	0.00299	CcSEcCtD
Griseofulvin—Erythema—Gemcitabine—lung cancer	0.000153	0.00298	CcSEcCtD
Griseofulvin—Feeling abnormal—Topotecan—lung cancer	0.00015	0.00291	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—lung cancer	0.000148	0.00288	CcSEcCtD
Griseofulvin—Nausea—Teniposide—lung cancer	0.000146	0.00283	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—lung cancer	0.000146	0.00283	CcSEcCtD
Griseofulvin—Urticaria—Topotecan—lung cancer	0.000145	0.00281	CcSEcCtD
Griseofulvin—Erythema—Cisplatin—lung cancer	0.000143	0.00278	CcSEcCtD
Griseofulvin—Erythema multiforme—Etoposide—lung cancer	0.000142	0.00276	CcSEcCtD
Griseofulvin—Leukopenia—Irinotecan—lung cancer	0.000141	0.00274	CcSEcCtD
Griseofulvin—Paraesthesia—Vinorelbine—lung cancer	0.00014	0.00272	CcSEcCtD
Griseofulvin—Erythema multiforme—Paclitaxel—lung cancer	0.000139	0.00271	CcSEcCtD
Griseofulvin—Hypersensitivity—Vinblastine—lung cancer	0.000138	0.00268	CcSEcCtD
Griseofulvin—Leukopenia—Gemcitabine—lung cancer	0.000137	0.00267	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Docetaxel—lung cancer	0.000136	0.00265	CcSEcCtD
Griseofulvin—Asthenia—Vinblastine—lung cancer	0.000134	0.00261	CcSEcCtD
Griseofulvin—Fatigue—Vinorelbine—lung cancer	0.000134	0.00261	CcSEcCtD
Griseofulvin—Hypersensitivity—Topotecan—lung cancer	0.000134	0.00261	CcSEcCtD
Griseofulvin—Asthenia—Topotecan—lung cancer	0.000131	0.00254	CcSEcCtD
Griseofulvin—Agranulocytosis—Docetaxel—lung cancer	0.00013	0.00252	CcSEcCtD
Griseofulvin—Confusional state—Irinotecan—lung cancer	0.000129	0.00252	CcSEcCtD
Griseofulvin—Asthenia—Erlotinib—lung cancer	0.000129	0.00251	CcSEcCtD
Griseofulvin—Erythema—Paclitaxel—lung cancer	0.000128	0.00249	CcSEcCtD
Griseofulvin—Feeling abnormal—Vinorelbine—lung cancer	0.000128	0.00249	CcSEcCtD
Griseofulvin—Diarrhoea—Vinblastine—lung cancer	0.000128	0.00249	CcSEcCtD
Griseofulvin—Leukopenia—Cisplatin—lung cancer	0.000128	0.00248	CcSEcCtD
Griseofulvin—Hepatitis—Docetaxel—lung cancer	0.000125	0.00243	CcSEcCtD
Griseofulvin—Diarrhoea—Topotecan—lung cancer	0.000125	0.00242	CcSEcCtD
Griseofulvin—Dizziness—Vinblastine—lung cancer	0.000124	0.00241	CcSEcCtD
Griseofulvin—Urticaria—Vinorelbine—lung cancer	0.000124	0.0024	CcSEcCtD
Griseofulvin—Diarrhoea—Erlotinib—lung cancer	0.000123	0.00239	CcSEcCtD
Griseofulvin—Dizziness—Topotecan—lung cancer	0.00012	0.00234	CcSEcCtD
Griseofulvin—Vomiting—Vinblastine—lung cancer	0.000119	0.00231	CcSEcCtD
Griseofulvin—Dizziness—Erlotinib—lung cancer	0.000119	0.00231	CcSEcCtD
Griseofulvin—Erythema multiforme—Docetaxel—lung cancer	0.000118	0.0023	CcSEcCtD
Griseofulvin—Headache—Vinblastine—lung cancer	0.000117	0.00228	CcSEcCtD
Griseofulvin—Angioedema—Paclitaxel—lung cancer	0.000117	0.00228	CcSEcCtD
Griseofulvin—Leukopenia—Etoposide—lung cancer	0.000117	0.00228	CcSEcCtD
Griseofulvin—Insomnia—Irinotecan—lung cancer	0.000116	0.00226	CcSEcCtD
Griseofulvin—Vomiting—Topotecan—lung cancer	0.000116	0.00225	CcSEcCtD
Griseofulvin—Paraesthesia—Irinotecan—lung cancer	0.000115	0.00224	CcSEcCtD
Griseofulvin—Leukopenia—Paclitaxel—lung cancer	0.000115	0.00223	CcSEcCtD
Griseofulvin—Rash—Topotecan—lung cancer	0.000115	0.00223	CcSEcCtD
Griseofulvin—Hypersensitivity—Vinorelbine—lung cancer	0.000115	0.00223	CcSEcCtD
Griseofulvin—Dermatitis—Topotecan—lung cancer	0.000115	0.00223	CcSEcCtD
Griseofulvin—Vomiting—Erlotinib—lung cancer	0.000114	0.00223	CcSEcCtD
Griseofulvin—Headache—Topotecan—lung cancer	0.000114	0.00222	CcSEcCtD
Griseofulvin—Rash—Erlotinib—lung cancer	0.000114	0.00221	CcSEcCtD
Griseofulvin—Dermatitis—Erlotinib—lung cancer	0.000113	0.0022	CcSEcCtD
Griseofulvin—Insomnia—Gemcitabine—lung cancer	0.000113	0.0022	CcSEcCtD
Griseofulvin—Dyspepsia—Irinotecan—lung cancer	0.000113	0.0022	CcSEcCtD
Griseofulvin—Headache—Erlotinib—lung cancer	0.000113	0.00219	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000113	0.00219	CcSEcCtD
Griseofulvin—Paraesthesia—Gemcitabine—lung cancer	0.000112	0.00218	CcSEcCtD
Griseofulvin—Asthenia—Vinorelbine—lung cancer	0.000112	0.00217	CcSEcCtD
Griseofulvin—Nausea—Vinblastine—lung cancer	0.000111	0.00216	CcSEcCtD
Griseofulvin—Fatigue—Irinotecan—lung cancer	0.000111	0.00215	CcSEcCtD
Griseofulvin—Erythema—Docetaxel—lung cancer	0.000109	0.00211	CcSEcCtD
Griseofulvin—Nausea—Topotecan—lung cancer	0.000108	0.0021	CcSEcCtD
Griseofulvin—Fatigue—Gemcitabine—lung cancer	0.000108	0.0021	CcSEcCtD
Griseofulvin—Confusional state—Etoposide—lung cancer	0.000108	0.00209	CcSEcCtD
Griseofulvin—Nausea—Erlotinib—lung cancer	0.000107	0.00208	CcSEcCtD
Griseofulvin—Diarrhoea—Vinorelbine—lung cancer	0.000107	0.00207	CcSEcCtD
Griseofulvin—Feeling abnormal—Irinotecan—lung cancer	0.000106	0.00206	CcSEcCtD
Griseofulvin—Confusional state—Paclitaxel—lung cancer	0.000106	0.00205	CcSEcCtD
Griseofulvin—Paraesthesia—Cisplatin—lung cancer	0.000105	0.00203	CcSEcCtD
Griseofulvin—Feeling abnormal—Gemcitabine—lung cancer	0.000103	0.002	CcSEcCtD
Griseofulvin—Dizziness—Vinorelbine—lung cancer	0.000103	0.002	CcSEcCtD
Griseofulvin—Vomiting—Vinorelbine—lung cancer	9.9e-05	0.00192	CcSEcCtD
Griseofulvin—Rash—Vinorelbine—lung cancer	9.82e-05	0.00191	CcSEcCtD
Griseofulvin—Dermatitis—Vinorelbine—lung cancer	9.81e-05	0.00191	CcSEcCtD
Griseofulvin—Headache—Vinorelbine—lung cancer	9.75e-05	0.0019	CcSEcCtD
Griseofulvin—Leukopenia—Docetaxel—lung cancer	9.74e-05	0.00189	CcSEcCtD
Griseofulvin—Feeling abnormal—Cisplatin—lung cancer	9.61e-05	0.00187	CcSEcCtD
Griseofulvin—Paraesthesia—Etoposide—lung cancer	9.59e-05	0.00186	CcSEcCtD
Griseofulvin—Insomnia—Paclitaxel—lung cancer	9.47e-05	0.00184	CcSEcCtD
Griseofulvin—Hypersensitivity—Irinotecan—lung cancer	9.46e-05	0.00184	CcSEcCtD
Griseofulvin—Paraesthesia—Paclitaxel—lung cancer	9.4e-05	0.00183	CcSEcCtD
Griseofulvin—Agranulocytosis—Methotrexate—lung cancer	9.36e-05	0.00182	CcSEcCtD
Griseofulvin—Nausea—Vinorelbine—lung cancer	9.25e-05	0.0018	CcSEcCtD
Griseofulvin—Dyspepsia—Paclitaxel—lung cancer	9.22e-05	0.00179	CcSEcCtD
Griseofulvin—Asthenia—Irinotecan—lung cancer	9.21e-05	0.00179	CcSEcCtD
Griseofulvin—Fatigue—Etoposide—lung cancer	9.21e-05	0.00179	CcSEcCtD
Griseofulvin—Fatigue—Paclitaxel—lung cancer	9.03e-05	0.00175	CcSEcCtD
Griseofulvin—Hepatitis—Methotrexate—lung cancer	9e-05	0.00175	CcSEcCtD
Griseofulvin—Asthenia—Gemcitabine—lung cancer	8.97e-05	0.00174	CcSEcCtD
Griseofulvin—Confusional state—Docetaxel—lung cancer	8.95e-05	0.00174	CcSEcCtD
Griseofulvin—Feeling abnormal—Etoposide—lung cancer	8.8e-05	0.00171	CcSEcCtD
Griseofulvin—Diarrhoea—Irinotecan—lung cancer	8.79e-05	0.00171	CcSEcCtD
Griseofulvin—Feeling abnormal—Paclitaxel—lung cancer	8.63e-05	0.00168	CcSEcCtD
Griseofulvin—Hypersensitivity—Cisplatin—lung cancer	8.59e-05	0.00167	CcSEcCtD
Griseofulvin—Diarrhoea—Gemcitabine—lung cancer	8.56e-05	0.00166	CcSEcCtD
Griseofulvin—Erythema multiforme—Methotrexate—lung cancer	8.51e-05	0.00165	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—lung cancer	8.51e-05	0.00165	CcSEcCtD
Griseofulvin—Dizziness—Irinotecan—lung cancer	8.49e-05	0.00165	CcSEcCtD
Griseofulvin—Urticaria—Etoposide—lung cancer	8.48e-05	0.00165	CcSEcCtD
Griseofulvin—Asthenia—Cisplatin—lung cancer	8.36e-05	0.00163	CcSEcCtD
Griseofulvin—Urticaria—Paclitaxel—lung cancer	8.32e-05	0.00162	CcSEcCtD
Griseofulvin—Vomiting—Irinotecan—lung cancer	8.16e-05	0.00159	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—lung cancer	8.11e-05	0.00158	CcSEcCtD
Griseofulvin—Rash—Irinotecan—lung cancer	8.1e-05	0.00157	CcSEcCtD
Griseofulvin—Dermatitis—Irinotecan—lung cancer	8.09e-05	0.00157	CcSEcCtD
Griseofulvin—Headache—Irinotecan—lung cancer	8.04e-05	0.00156	CcSEcCtD
Griseofulvin—Insomnia—Docetaxel—lung cancer	8.03e-05	0.00156	CcSEcCtD
Griseofulvin—Diarrhoea—Cisplatin—lung cancer	7.98e-05	0.00155	CcSEcCtD
Griseofulvin—Paraesthesia—Docetaxel—lung cancer	7.97e-05	0.00155	CcSEcCtD
Griseofulvin—Vomiting—Gemcitabine—lung cancer	7.95e-05	0.00155	CcSEcCtD
Griseofulvin—Rash—Gemcitabine—lung cancer	7.89e-05	0.00153	CcSEcCtD
Griseofulvin—Dermatitis—Gemcitabine—lung cancer	7.88e-05	0.00153	CcSEcCtD
Griseofulvin—Hypersensitivity—Etoposide—lung cancer	7.87e-05	0.00153	CcSEcCtD
Griseofulvin—Erythema—Methotrexate—lung cancer	7.84e-05	0.00152	CcSEcCtD
Griseofulvin—Headache—Gemcitabine—lung cancer	7.84e-05	0.00152	CcSEcCtD
Griseofulvin—Dyspepsia—Docetaxel—lung cancer	7.81e-05	0.00152	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—lung cancer	7.8e-05	0.00152	CcSEcCtD
Griseofulvin—Hypersensitivity—Paclitaxel—lung cancer	7.72e-05	0.0015	CcSEcCtD
Griseofulvin—Asthenia—Etoposide—lung cancer	7.66e-05	0.00149	CcSEcCtD
Griseofulvin—Fatigue—Docetaxel—lung cancer	7.65e-05	0.00149	CcSEcCtD
Griseofulvin—Nausea—Irinotecan—lung cancer	7.63e-05	0.00148	CcSEcCtD
Griseofulvin—Asthenia—Paclitaxel—lung cancer	7.51e-05	0.00146	CcSEcCtD
Griseofulvin—Nausea—Gemcitabine—lung cancer	7.43e-05	0.00144	CcSEcCtD
Griseofulvin—Vomiting—Cisplatin—lung cancer	7.41e-05	0.00144	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—lung cancer	7.37e-05	0.00143	CcSEcCtD
Griseofulvin—Rash—Cisplatin—lung cancer	7.35e-05	0.00143	CcSEcCtD
Griseofulvin—Dermatitis—Cisplatin—lung cancer	7.34e-05	0.00143	CcSEcCtD
Griseofulvin—Feeling abnormal—Docetaxel—lung cancer	7.31e-05	0.00142	CcSEcCtD
Griseofulvin—Diarrhoea—Etoposide—lung cancer	7.31e-05	0.00142	CcSEcCtD
Griseofulvin—Diarrhoea—Paclitaxel—lung cancer	7.17e-05	0.00139	CcSEcCtD
Griseofulvin—Dizziness—Etoposide—lung cancer	7.06e-05	0.00137	CcSEcCtD
Griseofulvin—Leukopenia—Methotrexate—lung cancer	7.02e-05	0.00136	CcSEcCtD
Griseofulvin—Dizziness—Paclitaxel—lung cancer	6.93e-05	0.00135	CcSEcCtD
Griseofulvin—Nausea—Cisplatin—lung cancer	6.92e-05	0.00135	CcSEcCtD
Griseofulvin—Vomiting—Etoposide—lung cancer	6.79e-05	0.00132	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—lung cancer	6.79e-05	0.00132	CcSEcCtD
Griseofulvin—Rash—Etoposide—lung cancer	6.73e-05	0.00131	CcSEcCtD
Griseofulvin—Dermatitis—Etoposide—lung cancer	6.73e-05	0.00131	CcSEcCtD
Griseofulvin—Headache—Etoposide—lung cancer	6.69e-05	0.0013	CcSEcCtD
Griseofulvin—Vomiting—Paclitaxel—lung cancer	6.66e-05	0.00129	CcSEcCtD
Griseofulvin—Rash—Paclitaxel—lung cancer	6.6e-05	0.00128	CcSEcCtD
Griseofulvin—Dermatitis—Paclitaxel—lung cancer	6.6e-05	0.00128	CcSEcCtD
Griseofulvin—Headache—Paclitaxel—lung cancer	6.56e-05	0.00127	CcSEcCtD
Griseofulvin—Hypersensitivity—Docetaxel—lung cancer	6.54e-05	0.00127	CcSEcCtD
Griseofulvin—Confusional state—Methotrexate—lung cancer	6.45e-05	0.00125	CcSEcCtD
Griseofulvin—Asthenia—Docetaxel—lung cancer	6.37e-05	0.00124	CcSEcCtD
Griseofulvin—Nausea—Etoposide—lung cancer	6.34e-05	0.00123	CcSEcCtD
Griseofulvin—Nausea—Paclitaxel—lung cancer	6.22e-05	0.00121	CcSEcCtD
Griseofulvin—Leukopenia—Doxorubicin—lung cancer	6.08e-05	0.00118	CcSEcCtD
Griseofulvin—Diarrhoea—Docetaxel—lung cancer	6.07e-05	0.00118	CcSEcCtD
Griseofulvin—Dizziness—Docetaxel—lung cancer	5.87e-05	0.00114	CcSEcCtD
Griseofulvin—Insomnia—Methotrexate—lung cancer	5.79e-05	0.00112	CcSEcCtD
Griseofulvin—Paraesthesia—Methotrexate—lung cancer	5.74e-05	0.00112	CcSEcCtD
Griseofulvin—Vomiting—Docetaxel—lung cancer	5.64e-05	0.0011	CcSEcCtD
Griseofulvin—Dyspepsia—Methotrexate—lung cancer	5.63e-05	0.00109	CcSEcCtD
Griseofulvin—Rash—Docetaxel—lung cancer	5.6e-05	0.00109	CcSEcCtD
Griseofulvin—Dermatitis—Docetaxel—lung cancer	5.59e-05	0.00109	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—lung cancer	5.59e-05	0.00109	CcSEcCtD
Griseofulvin—Headache—Docetaxel—lung cancer	5.56e-05	0.00108	CcSEcCtD
Griseofulvin—Fatigue—Methotrexate—lung cancer	5.52e-05	0.00107	CcSEcCtD
Griseofulvin—Nausea—Docetaxel—lung cancer	5.27e-05	0.00102	CcSEcCtD
Griseofulvin—Feeling abnormal—Methotrexate—lung cancer	5.27e-05	0.00102	CcSEcCtD
Griseofulvin—Urticaria—Methotrexate—lung cancer	5.08e-05	0.000988	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—lung cancer	5.01e-05	0.000974	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—lung cancer	4.97e-05	0.000967	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—lung cancer	4.88e-05	0.000948	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—lung cancer	4.81e-05	0.00429	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	4.78e-05	0.00426	CbGpPWpGaD
Griseofulvin—Fatigue—Doxorubicin—lung cancer	4.78e-05	0.000928	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA4—lung cancer	4.77e-05	0.00426	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	4.77e-05	0.00426	CbGpPWpGaD
Griseofulvin—Hypersensitivity—Methotrexate—lung cancer	4.71e-05	0.000916	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA2—lung cancer	4.65e-05	0.00415	CbGpPWpGaD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	4.62e-05	0.00412	CbGpPWpGaD
Griseofulvin—Asthenia—Methotrexate—lung cancer	4.59e-05	0.000892	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—lung cancer	4.56e-05	0.000887	CcSEcCtD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—lung cancer	4.56e-05	0.00407	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTA1—lung cancer	4.49e-05	0.004	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—STAT3—lung cancer	4.45e-05	0.00397	CbGpPWpGaD
Griseofulvin—Urticaria—Doxorubicin—lung cancer	4.4e-05	0.000855	CcSEcCtD
Griseofulvin—Diarrhoea—Methotrexate—lung cancer	4.38e-05	0.000851	CcSEcCtD
Griseofulvin—Dizziness—Methotrexate—lung cancer	4.23e-05	0.000822	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—UGT1A1—lung cancer	4.17e-05	0.00372	CbGpPWpGaD
Griseofulvin—Hypersensitivity—Doxorubicin—lung cancer	4.08e-05	0.000793	CcSEcCtD
Griseofulvin—Vomiting—Methotrexate—lung cancer	4.07e-05	0.00079	CcSEcCtD
Griseofulvin—Rash—Methotrexate—lung cancer	4.03e-05	0.000784	CcSEcCtD
Griseofulvin—Dermatitis—Methotrexate—lung cancer	4.03e-05	0.000783	CcSEcCtD
Griseofulvin—Headache—Methotrexate—lung cancer	4.01e-05	0.000779	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—lung cancer	3.97e-05	0.000772	CcSEcCtD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	3.93e-05	0.00351	CbGpPWpGaD
Griseofulvin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	3.91e-05	0.00349	CbGpPWpGaD
Griseofulvin—CYP1A2—Tryptophan metabolism—CAT—lung cancer	3.9e-05	0.00348	CbGpPWpGaD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—lung cancer	3.88e-05	0.00346	CbGpPWpGaD
Griseofulvin—Nausea—Methotrexate—lung cancer	3.8e-05	0.000738	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—lung cancer	3.79e-05	0.000737	CcSEcCtD
Griseofulvin—CYP1A2—Biological oxidations—GSTM2—lung cancer	3.79e-05	0.00338	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CNDP2—lung cancer	3.79e-05	0.00338	CbGpPWpGaD
Griseofulvin—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	3.75e-05	0.00335	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	3.75e-05	0.00334	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTM2—lung cancer	3.74e-05	0.00333	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	3.73e-05	0.00333	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	3.7e-05	0.00331	CbGpPWpGaD
Griseofulvin—Dizziness—Doxorubicin—lung cancer	3.66e-05	0.000712	CcSEcCtD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	3.57e-05	0.00318	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—HPGDS—lung cancer	3.55e-05	0.00317	CbGpPWpGaD
Griseofulvin—Vomiting—Doxorubicin—lung cancer	3.52e-05	0.000684	CcSEcCtD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	3.52e-05	0.00314	CbGpPWpGaD
Griseofulvin—Rash—Doxorubicin—lung cancer	3.49e-05	0.000679	CcSEcCtD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	3.49e-05	0.00312	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	3.49e-05	0.00312	CbGpPWpGaD
Griseofulvin—CYP1A2—Tryptophan metabolism—CYP1A1—lung cancer	3.49e-05	0.00312	CbGpPWpGaD
Griseofulvin—Dermatitis—Doxorubicin—lung cancer	3.49e-05	0.000678	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—lung cancer	3.47e-05	0.000674	CcSEcCtD
Griseofulvin—CYP1A2—Phase II conjugation—GSTT1—lung cancer	3.44e-05	0.00307	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP2A7—lung cancer	3.43e-05	0.00306	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GCLC—lung cancer	3.4e-05	0.00303	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP2A7—lung cancer	3.38e-05	0.00301	CbGpPWpGaD
Griseofulvin—Nausea—Doxorubicin—lung cancer	3.29e-05	0.000639	CcSEcCtD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—CYP1A1—lung cancer	3.27e-05	0.00291	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	3.19e-05	0.00284	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA3—lung cancer	3.05e-05	0.00272	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	3.03e-05	0.00271	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTA3—lung cancer	3.01e-05	0.00269	CbGpPWpGaD
Griseofulvin—CYP3A4—Tryptophan metabolism—CAT—lung cancer	3.01e-05	0.00269	CbGpPWpGaD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	2.99e-05	0.00267	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CNDP2—lung cancer	2.92e-05	0.00261	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTM2—lung cancer	2.92e-05	0.00261	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	2.89e-05	0.00258	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	2.88e-05	0.00257	CbGpPWpGaD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	2.82e-05	0.00252	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA4—lung cancer	2.79e-05	0.00249	CbGpPWpGaD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—lung cancer	2.79e-05	0.00249	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTA4—lung cancer	2.75e-05	0.00246	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA2—lung cancer	2.72e-05	0.00243	CbGpPWpGaD
Griseofulvin—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	2.69e-05	0.0024	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP2A7—lung cancer	2.64e-05	0.00236	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTA1—lung cancer	2.63e-05	0.00234	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	2.61e-05	0.00233	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	2.53e-05	0.00225	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	2.48e-05	0.00221	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	2.46e-05	0.00219	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—UGT1A1—lung cancer	2.44e-05	0.00218	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	2.42e-05	0.00216	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	2.41e-05	0.00215	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	2.4e-05	0.00214	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTP1—lung cancer	2.39e-05	0.00213	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA3—lung cancer	2.36e-05	0.0021	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	2.32e-05	0.00207	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	2.29e-05	0.00204	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTM1—lung cancer	2.19e-05	0.00196	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	2.18e-05	0.00194	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA4—lung cancer	2.16e-05	0.00192	CbGpPWpGaD
Griseofulvin—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	2.15e-05	0.00192	CbGpPWpGaD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	2.15e-05	0.00192	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	2.15e-05	0.00192	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	2.13e-05	0.0019	CbGpPWpGaD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	2.1e-05	0.00188	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA2—lung cancer	2.1e-05	0.00187	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	2.08e-05	0.00185	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—HPGDS—lung cancer	2.08e-05	0.00185	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTA1—lung cancer	2.03e-05	0.00181	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTT1—lung cancer	2.01e-05	0.0018	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP2A6—lung cancer	1.99e-05	0.00178	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GCLC—lung cancer	1.99e-05	0.00178	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	1.94e-05	0.00173	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	1.92e-05	0.00172	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	1.91e-05	0.00171	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—UGT1A1—lung cancer	1.88e-05	0.00168	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	1.87e-05	0.00167	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	1.86e-05	0.00166	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	1.82e-05	0.00162	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	1.82e-05	0.00162	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	1.77e-05	0.00158	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	1.73e-05	0.00154	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	1.73e-05	0.00154	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	1.71e-05	0.00152	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP2E1—lung cancer	1.69e-05	0.00151	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	1.68e-05	0.0015	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	1.68e-05	0.0015	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	1.67e-05	0.00149	CbGpPWpGaD
Griseofulvin—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	1.66e-05	0.00148	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	1.64e-05	0.00146	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	1.62e-05	0.00145	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	1.62e-05	0.00144	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—HPGDS—lung cancer	1.6e-05	0.00143	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTT1—lung cancer	1.55e-05	0.00139	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP2A6—lung cancer	1.54e-05	0.00137	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GCLC—lung cancer	1.54e-05	0.00137	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	1.51e-05	0.00134	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	1.47e-05	0.00131	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	1.47e-05	0.00131	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	1.42e-05	0.00126	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTP1—lung cancer	1.4e-05	0.00125	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	1.39e-05	0.00124	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	1.38e-05	0.00123	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	1.32e-05	0.00117	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP2E1—lung cancer	1.31e-05	0.00117	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	1.29e-05	0.00115	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTM1—lung cancer	1.28e-05	0.00114	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	1.26e-05	0.00113	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP1A1—lung cancer	1.22e-05	0.00108	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	1.2e-05	0.00107	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	1.18e-05	0.00105	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.08e-05	0.000961	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AZIN2—lung cancer	1.07e-05	0.000954	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—COL4A3BP—lung cancer	1.07e-05	0.000954	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.06e-05	0.000948	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	9.97e-06	0.00089	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTM1—lung cancer	9.9e-06	0.000883	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	9.76e-06	0.000871	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	9.66e-06	0.000862	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	9.38e-06	0.000837	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	9.25e-06	0.000826	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ATP5H—lung cancer	9.09e-06	0.000811	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—POMC—lung cancer	9.06e-06	0.000809	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	8.36e-06	0.000745	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—COL4A3BP—lung cancer	8.25e-06	0.000736	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AZIN2—lung cancer	8.25e-06	0.000736	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PLBD1—lung cancer	8.1e-06	0.000723	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.97e-06	0.000711	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HSD17B10—lung cancer	7.41e-06	0.000661	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ATP5H—lung cancer	7.02e-06	0.000626	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—POMC—lung cancer	7e-06	0.000624	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CKB—lung cancer	6.89e-06	0.000615	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM2—lung cancer	6.48e-06	0.000578	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CNDP2—lung cancer	6.48e-06	0.000578	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MTMR3—lung cancer	6.3e-06	0.000562	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PLBD1—lung cancer	6.25e-06	0.000558	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PGAM1—lung cancer	6.14e-06	0.000548	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2A7—lung cancer	5.86e-06	0.000523	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SDC4—lung cancer	5.73e-06	0.000512	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HSD17B10—lung cancer	5.72e-06	0.00051	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CKB—lung cancer	5.32e-06	0.000474	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—RRM1—lung cancer	5.22e-06	0.000466	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA3—lung cancer	5.22e-06	0.000466	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM2—lung cancer	5e-06	0.000446	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CNDP2—lung cancer	5e-06	0.000446	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—B4GALT5—lung cancer	4.91e-06	0.000438	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MTMR3—lung cancer	4.86e-06	0.000434	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA4—lung cancer	4.78e-06	0.000426	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PGAM1—lung cancer	4.74e-06	0.000423	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.67e-06	0.000416	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA2—lung cancer	4.65e-06	0.000415	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2A7—lung cancer	4.52e-06	0.000403	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTA1—lung cancer	4.49e-06	0.000401	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ABCC3—lung cancer	4.44e-06	0.000396	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SDC4—lung cancer	4.43e-06	0.000395	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AKR1C1—lung cancer	4.3e-06	0.000384	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UGT1A1—lung cancer	4.18e-06	0.000372	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA3—lung cancer	4.03e-06	0.00036	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—RRM1—lung cancer	4.03e-06	0.00036	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GNG11—lung cancer	4.03e-06	0.000359	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.01e-06	0.000357	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ALDOA—lung cancer	3.83e-06	0.000342	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—B4GALT5—lung cancer	3.79e-06	0.000338	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NCOA3—lung cancer	3.72e-06	0.000332	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA4—lung cancer	3.69e-06	0.000329	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.66e-06	0.000326	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ADCY1—lung cancer	3.62e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ABCG2—lung cancer	3.62e-06	0.000323	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA2—lung cancer	3.59e-06	0.00032	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HPGDS—lung cancer	3.55e-06	0.000317	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ENO2—lung cancer	3.55e-06	0.000317	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.53e-06	0.000315	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.48e-06	0.000311	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTA1—lung cancer	3.47e-06	0.000309	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTT1—lung cancer	3.44e-06	0.000307	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ABCC3—lung cancer	3.43e-06	0.000306	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GCLC—lung cancer	3.4e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2A6—lung cancer	3.4e-06	0.000304	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.39e-06	0.000302	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AKR1C1—lung cancer	3.32e-06	0.000296	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ENO1—lung cancer	3.23e-06	0.000288	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UGT1A1—lung cancer	3.22e-06	0.000287	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.21e-06	0.000287	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.17e-06	0.000283	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GNG11—lung cancer	3.11e-06	0.000277	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ALDOA—lung cancer	2.96e-06	0.000264	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP2E1—lung cancer	2.89e-06	0.000258	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NCOA3—lung cancer	2.87e-06	0.000256	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NQO1—lung cancer	2.86e-06	0.000255	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.8e-06	0.00025	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ABCG2—lung cancer	2.79e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ADCY1—lung cancer	2.79e-06	0.000249	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.78e-06	0.000248	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ENO2—lung cancer	2.74e-06	0.000244	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HPGDS—lung cancer	2.74e-06	0.000244	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.72e-06	0.000243	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTT1—lung cancer	2.66e-06	0.000237	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GCLC—lung cancer	2.63e-06	0.000234	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2A6—lung cancer	2.63e-06	0.000234	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—STK11—lung cancer	2.58e-06	0.00023	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ENO1—lung cancer	2.49e-06	0.000222	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.42e-06	0.000216	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTP1—lung cancer	2.39e-06	0.000213	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CAT—lung cancer	2.32e-06	0.000207	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.31e-06	0.000206	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ABCB1—lung cancer	2.26e-06	0.000202	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP2E1—lung cancer	2.23e-06	0.000199	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TYMS—lung cancer	2.22e-06	0.000198	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NQO1—lung cancer	2.21e-06	0.000197	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM1—lung cancer	2.19e-06	0.000196	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP1A1—lung cancer	2.08e-06	0.000185	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ERCC2—lung cancer	2.06e-06	0.000184	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—STK11—lung cancer	1.99e-06	0.000178	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTP1—lung cancer	1.84e-06	0.000164	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CAT—lung cancer	1.79e-06	0.00016	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—APOA1—lung cancer	1.78e-06	0.000159	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ABCB1—lung cancer	1.74e-06	0.000156	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TYMS—lung cancer	1.71e-06	0.000153	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.71e-06	0.000152	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM1—lung cancer	1.69e-06	0.000151	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CG—lung cancer	1.63e-06	0.000145	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP1A1—lung cancer	1.6e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ERCC2—lung cancer	1.59e-06	0.000142	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—POMC—lung cancer	1.55e-06	0.000138	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CREBBP—lung cancer	1.51e-06	0.000135	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CD—lung cancer	1.43e-06	0.000128	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ALB—lung cancer	1.41e-06	0.000126	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—APOA1—lung cancer	1.38e-06	0.000123	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CG—lung cancer	1.26e-06	0.000112	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CB—lung cancer	1.25e-06	0.000111	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTGS2—lung cancer	1.24e-06	0.00011	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—POMC—lung cancer	1.2e-06	0.000107	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CREBBP—lung cancer	1.17e-06	0.000104	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CD—lung cancer	1.1e-06	9.86e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ALB—lung cancer	1.09e-06	9.73e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTEN—lung cancer	1.08e-06	9.62e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—EP300—lung cancer	1.03e-06	9.17e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CB—lung cancer	9.63e-07	8.59e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTGS2—lung cancer	9.54e-07	8.51e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTEN—lung cancer	8.32e-07	7.42e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—EP300—lung cancer	7.94e-07	7.08e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PIK3CA—lung cancer	7.61e-07	6.79e-05	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—AKT1—lung cancer	6.21e-07	5.54e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PIK3CA—lung cancer	5.87e-07	5.24e-05	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—AKT1—lung cancer	4.8e-07	4.28e-05	CbGpPWpGaD
